|
||||||
| |
|
Increased Postpartum Susceptibility to Malaria Alendronate for the Treatment of Osteoporosis in Men In
this study, 241 men ranging in age from 31 to 87 years who had osteoporosis
that was idiopathic or associated with low serum testosterone values were
given 10 mg of alendronate or placebo daily for two years. Bone mineral
density of the lumbar spine, hip, and total body progressively increased
by a mean of 7.1, 3.1, and 2.0 percent, respectively, in the alendronate
group, as compared with respective increases of 1.8, 0.6, and 0.4 percent
in the placebo group. The men in the alendronate group also had fewer vertebral
fractures and smaller decreases in height.
Predictors of Outcome in Severe, Asymptomatic Aortic Stenosis Spinal Cord Stimulation in Reflex Sympathetic Dystrophy |
||||
|
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |